Arunasalam Dharmarajan
Overview
Explore the profile of Arunasalam Dharmarajan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
511
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sivarajan V, Ganesh A, Subramani P, Ganesapandi P, Sivanandan R, Prakash S, et al.
Sci Rep
. 2025 Jan;
15(1):2541.
PMID: 39833199
Urinary tract infections are a common condition affecting people globally, with multidrug-resistant (MDR) Escherichia coli (E. coli) being a major causative agent. Antimicrobial susceptibility profiling was performed using the VITEK...
2.
Ben Kridis W, Wang Z, Guven D, Dharmarajan A
Front Oncol
. 2024 Oct;
14:1449566.
PMID: 39386197
No abstract available.
3.
Kalachaveedu M, Senthil R, Azhagiyamanavalan S, Ravi R, Meenakshisundaram H, Dharmarajan A
Phytother Res
. 2023 Feb;
37(4):1539-1573.
PMID: 36788644
Emerging evidence on molecular biology related to tumors, inflammation, and immunity, highlights their architectural commonality shifting cancer treatment paradigms toward more economical prevention than treatment. Statistical surveys reveal exponentially growing...
4.
Soundararajan L, Dharmarajan A, Samji P
Cell Signal
. 2022 Oct;
101:110496.
PMID: 36252791
Nitric Oxide (NO) is a highly diffusible, ubiquitous signaling molecule and a free radical that is naturally synthesized by our body. The pleiotropic effects of NO in biological systems are...
5.
Shanmugam M, Dharmarajan A, Warrier S, Bishayee A, Kumar A, Sethi G, et al.
Adv Protein Chem Struct Biol
. 2021 May;
125:149-191.
PMID: 33931138
The development of cancer is a complex phenomenon driven by various extrinsic as well as intrinsic risk factors including epigenetic modifications. These post-translational modifications are encountered in diverse cancer cells...
6.
Ma Z, Wang Y, Xin H, Wang L, Arfuso F, Dharmarajan A, et al.
Int J Biochem Cell Biol
. 2019 Jan;
108:17-20.
PMID: 30630112
Long non-coding RNAs (lncRNAs) are a novel class of gene regulators playing multifaceted roles in physiological processes as well as pathological conditions such as cancer. Cancer stem cells (CSCs) are...
7.
Bordoloi D, Banik K, Shabnam B, Padmavathi G, Monisha J, Arfuso F, et al.
Int J Mol Sci
. 2018 Oct;
19(10).
PMID: 30274259
The tumor necrosis factor-α-induced protein 8-like (TIPE/TNFAIP8) family is a recently identified family of proteins that is strongly associated with the regulation of immunity and tumorigenesis. This family is comprised...
8.
Dai X, Wang L, Deivasigamni A, Looi C, Karthikeyan C, Trivedi P, et al.
Oncotarget
. 2017 Jan;
8(8):12831-12842.
PMID: 28086233
A prior screening programme carried out using MTT assay by our group identified a series of novel benzimidazole derivatives, among which Methyl 2-(5-fluoro-2-hydroxyphenyl)-1H- benzo[d]imidazole-5-carboxylate (MBIC) showed highest anticancer efficacy compared...
9.
Swamy S, Kameshwar V, Shubha P, Looi C, Shanmugam M, Arfuso F, et al.
Target Oncol
. 2016 Aug;
12(1):1-10.
PMID: 27510230
Hepatocellular carcinoma (HCC) is one of the most common forms of liver cancer diagnosed worldwide. HCC occurs due to chronic liver disease and is often diagnosed at advanced stages. Chemotherapeutic...
10.
Shanmugam M, Lee J, Chai E, Mathi Kanchi M, Kar S, Arfuso F, et al.
Semin Cancer Biol
. 2016 Apr;
40-41:35-47.
PMID: 27038646
The association between chronic inflammation and cancer development has been well documented. One of the major obstacles in cancer treatment is the persistent autocrine and paracrine activation of pro-inflammatory transcription...